American Portfolios Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

American Portfolios Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-150	Closed	-$3.58K	–	3494
2021 Q1	$3.58K	Hold	150	–	–	﹤0.01%	2817
2020 Q4	$2.19K	Hold	150	–	–	﹤0.01%	2679
2020 Q3	$2.13K	Hold	150	–	–	﹤0.01%	2587
2020 Q2	$2.21K	Buy	+150	New	+$1.52K	﹤0.01%	2520

American Portfolios Advisors's GNMK Position: Q2 2021 in Review

American Portfolios Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 150 shares — an estimated $3.58K sold.

American Portfolios Advisors first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $3.58K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

American Portfolios Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
American Portfolios Advisors sold 150 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $3.58K.
American Portfolios Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
American Portfolios Advisors's GenMark Diagnostics, Inc position peaked at $3.58K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on American Portfolios Advisors's 13F filing for Q2 2021, filed 22 Mar 2023.